US Patent 11753369 Creatine prodrugs, compositions and methods of use thereof

Is a

Patent

Patent attributes

Patent Applicant

Ultragenyx Pharmaceutical

Current Assignee

Ultragenyx Pharmaceutical

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11753369

Patent Inventor Names

William F. Brubaker

Arjun Natesan

Yiumo Chan

Mike E. Lizarzaburu

Alexandra Trotier-Faurion

Paul Lee

David Lapointe

Sharyl Fyffe-Maricich

...

Date of Patent

September 12, 2023

Patent Application Number

17706283

Date Filed

March 28, 2022

Patent Citations

‌

US Patent 11021501 Creatine phosphate analog prodrugs, compositions and methods of use thereof

‌

US Patent 11407722 Creatine prodrugs, compositions and methods of use thereof

‌

US Patent 11332438 Creatine prodrugs, compositions and methods of use thereof

‌

US Patent 7319157 Creatine-fatty acids

‌

US Patent 8350077 Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity

‌

US Patent 9233099 Methods of treating cognitive dysfunction by modulating brain energy metabolism

‌

US Patent 9617230 Creatine prodrugs, compositions and methods of use thereof

‌

US Patent 10344007 Creatine prodrugs, compositions and methods of use thereof

Patent Primary Examiner

‌

Joseph R Kosack

The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11753369 Creatine prodrugs, compositions and methods of use thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11753369 Creatine prodrugs, compositions and methods of use thereof